neoadjuvant therapy for breast cancer乳腺癌新辅助治疗.pdf,Neoadjuvanttherapyforbreastcancerinvolvesvarioustreatmentoptionssuchasneoadjuvantendocrinetherapy,neoadjuvanthormonaltherapy,andneoadjuvantimmunotherapyThesetherapiesaimtoreducetheriskofrecurrence
https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm#ctc_40 30. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457-481. doi:10.1080/01621459.1958.10501452 Google ScholarCrossref 31. Sadigh KS,...
Molecular profiling guides precision treatment of breast cancer; however, Asian patients are underrepresented in publicly available large-scale studies. We established a comprehensive multiomics cohort of 773 Chinese patients with breast cancer and systematically analyzed their genomic, transcriptomic, proteomic...
A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: s... A mobile application of breast cancer e-support program versus routine care in the treatment of Chinese women with breast cancer undergoing ...
Early life environmental exposures affect breast development and breast cancer risk in adulthood. The breast is particularly vulnerable during puberty when mammary epithelial cells proliferate exponentially. In overweight/obese (OB) women, inflammation i
MRI of the breast is increasingly used for the assessment and local staging of breast cancer as well for the screening of very-high-risk patients in the NHS breast screening programme. A dynamic contrast-enhanced protocol is used as well as other sequences. These sequences assess the inherent...
High levels of treatment satisfaction were found. The intervention was useful to improve the emotional regulation of women with a medical condition in a pandemic context. How to cite this paper: Arrigoni F & Navarro Guzmán JI (2024). Transdiagnostic Unified Protocol for Women with Breast Cancer:...
We have used SELDI-TOF MS to discover two proteins that, in combination, show high discrimination between breast cancer and healthy breast tissue samples. A limitation of the protocol was that no microdissection was used, and hence tissue samples could have contained heterogeneous cell types. Despit...
Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial. J Natl Cancer Inst. 2017;109(5). doi:10.1093/jnci/djw290PubMedGoogle ScholarCrossref 51. Roux A, Cholerton R, Sicsic J, et al. Study protocol comparing the ethical,...
The B-MaP-C study aimed to determine alterations to breast cancer (BC) management during the peak transmission period of the UK COVID-19 pandemic and the potential impact of these treatment decisions. This was a national cohort study of patients with ear